Literature DB >> 27650010

Exploring the Topics Discussed During a Conversation Card Game About Death and Dying: A Content Analysis.

Lauren Jodi Van Scoy1, Jean M Reading2, Allison M Scott3, Cynthia Chuang4, Benjamin H Levi5, Michael J Green6.   

Abstract

CONTEXT: Substantive discussions between loved ones are necessary for effective advance care planning. Although multiple tools are currently in use for promoting conversations, the content and clinical relevance of the conversations they stimulate is unknown.
OBJECTIVE: To describe the content and clinical relevance of conversations that occur during a nonfacilitated end-of-life conversation game.
METHODS: Using convenience sampling, we scheduled adult volunteers to participate in an end-of-life conversation game (2-6 individuals per game; n = 68). Participants discussed 20 questions about death, dying, or end-of-life issues. Games lasted up to two hours and were audio-recorded, transcribed, and analyzed using a conventional qualitative content analysis approach to identify emerging themes.
RESULTS: Participants (n = 68) were primarily Caucasian (94%), females (68%), with mean age of 51.3 years (SD 0.7). Seventeen games were analyzed. Four primary themes emerged during game conversations: 1) the importance of people, relationships, and the roles played during end-of-life decision making, 2) values, beliefs, and preferences related to end-of-life care and the dying period, 3) considerations about preparing for the aftermath of one's death, and 4) the relevance of stories or experiences for informing one's own end-of-life preferences.
CONCLUSIONS: Topics discussed during a nonfacilitated end-of-life conversation game are substantive and address important issues for advance care planning.
Copyright © 2016 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advance directives; communication; end-of-life care; medical decision making; palliative care; terminal care

Mesh:

Year:  2016        PMID: 27650010     DOI: 10.1016/j.jpainsymman.2016.03.021

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  5 in total

1.  Evaluating an Advance Care Planning Curriculum: a Lecture, a Game, a Patient, and an Essay.

Authors:  Lauren Jodi Van Scoy; Michael J Green; Rebecca Volpe
Journal:  Med Sci Educ       Date:  2019-03-04

2.  Low Skepticism and Positive Attitudes About Advance Care Planning Among African Americans: a National, Mixed Methods Cohort Study.

Authors:  Lauren Jodi Van Scoy; Michael J Green; Pamela D Witt; Cindy Bramble; Christopher Richardson; Irene Putzig; Olubukola Toyobo; Emily Wasserman; Vernon M Chinchilli; Amy Tucci; Benjamin H Levi
Journal:  J Gen Intern Med       Date:  2020-09-18       Impact factor: 5.128

3.  Individual, interpersonal, and health care factors associated with informal and formal advance care planning in a nationally-representative sample of midlife and older adults.

Authors:  Daniel Siconolfi; Julia Bandini; Emily Chen
Journal:  Patient Educ Couns       Date:  2020-12-25

4.  Association of Participation in an End-of-Life Conversation Game With Advance Care Planning Behavior and Perspectives Among African American Individuals.

Authors:  Lauren Jodi Van Scoy; Benjamin H Levi; Pamela Witt; Cindy Bramble; Christopher Richardson; Irene Putzig; A Rose Levi; Emily Wasserman; Vernon Chinchilli; Amy Tucci; Michael J Green
Journal:  JAMA Netw Open       Date:  2020-05-01

5.  Comparing two advance care planning conversation activities to motivate advance directive completion in underserved communities across the USA: The Project Talk Trial study protocol for a cluster, randomized controlled trial.

Authors:  Lauren J Van Scoy; Benjamin H Levi; Cindy Bramble; William Calo; Vernon M Chinchilli; Lindsey Currin; Denise Grant; Christopher Hollenbeak; Maria Katsaros; Sara Marlin; Allison M Scott; Amy Tucci; Erika VanDyke; Emily Wasserman; Pamela Witt; Michael J Green
Journal:  Trials       Date:  2022-09-30       Impact factor: 2.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.